Literature DB >> 20538986

Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling.

Cheng Luo1, Xiangjun Yang, Angela D Kain, David W Powell, Markus H Kuehn, Gülgün Tezel.   

Abstract

PURPOSE: To determine the regulation of immune system activity associated with Toll-like receptor (TLR) signaling in glaucoma.
METHODS: Retinal protein samples obtained from human donor eyes with (n = 10) or without (n = 10) glaucoma were analyzed by a quantitative proteomic approach involving mass spectrometry. Cellular localization of TLR2, -3, and -4 was also determined by immunohistochemical analysis of an additional group of human donor eyes with glaucoma (n = 34) and control eyes (n = 20). In addition, in vitro experiments were performed in rat retinal microglia and astrocytes to determine glial TLR expression and immunoregulatory function after exposure to exogenous heat shock proteins (HSPs) and H(2)O(2)-induced oxidative stress.
RESULTS: Proteomic analyses of the human retina detected expression and differential regulation of different TLRs in glaucomatous samples. Parallel to the upregulation of TLR signaling, proteomic findings were also consistent with a prominent increase in the expression of HSPs in glaucoma. Immunohistochemical analysis supported upregulated expression of TLRs on both microglia and astrocytes in the glaucomatous retina. In vitro experiments provided additional evidence that HSPs and oxidative stress upregulate glial TLR and MHC class II expression and cytokine production through TLR signaling and stimulate proliferation and cytokine secretion of co-cultured T cells during antigen presentation.
CONCLUSIONS: The findings of this study support the upregulation of TLR signaling in human glaucoma, which may be associated with innate and adaptive immune responses. In vitro findings showed that components of glaucomatous tissue stress, including upregulated HSPs and oxidative stress, may initiate the immunostimulatory signaling through glial TLRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538986      PMCID: PMC3061506          DOI: 10.1167/iovs.10-5407

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  78 in total

1.  The role of glia, mitochondria, and the immune system in glaucoma.

Authors:  Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03       Impact factor: 4.799

2.  Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.

Authors:  Conrad P Hodgkinson; Ross C Laxton; Kunal Patel; Shu Ye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

3.  Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Yali Wang; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

4.  Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.

Authors:  Sung-Chun Tang; Justin D Lathia; Pradeep K Selvaraj; Dong-Gyu Jo; Mohamed R Mughal; Aiwu Cheng; Dominic A Siler; William R Markesbery; Thiruma V Arumugam; Mark P Mattson
Journal:  Exp Neurol       Date:  2008-05-29       Impact factor: 5.330

5.  Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.

Authors:  Aurelia Lartigue; Natacha Colliou; Sébastien Calbo; Arnault François; Serge Jacquot; Christophe Arnoult; Francois Tron; Daniele Gilbert; Philippe Musette
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

6.  Toll-like receptor 2 is essential for the sensing of oxidants during inflammation.

Authors:  Mark J Paul-Clark; Shaun K McMaster; Rosalinda Sorrentino; Shiranee Sriskandan; Lucy K Bailey; Laura Moreno; Bernhard Ryffel; Valerie F Quesniaux; Jane A Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

7.  Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.

Authors:  Elena von Schlieffen; Olga V Oskolkova; Gernot Schabbauer; Florian Gruber; Stephan Blüml; Melinda Genest; Alexandra Kadl; Claudia Marsik; Sylvia Knapp; Jesse Chow; Norbert Leitinger; Bernd R Binder; Valery N Bochkov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-26       Impact factor: 8.311

8.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.

Authors:  Zhenglin Yang; Charity Stratton; Peter J Francis; Mark E Kleinman; Perciliz L Tan; Daniel Gibbs; Zongzhong Tong; Haoyu Chen; Ryan Constantine; Xian Yang; Yuhong Chen; Jiexi Zeng; Lisa Davey; Xiang Ma; Vincent S Hau; Chi Wang; Jennifer Harmon; Jeanette Buehler; Erik Pearson; Shrena Patel; Yuuki Kaminoh; Scott Watkins; Ling Luo; Norman A Zabriskie; Paul S Bernstein; Wongil Cho; Andrea Schwager; David R Hinton; Michael L Klein; Sara C Hamon; Emily Simmons; Beifeng Yu; Betsy Campochiaro; Janet S Sunness; Peter Campochiaro; Lynn Jorde; Giovanni Parmigiani; Donald J Zack; Nicholas Katsanis; Jayakrishna Ambati; Kang Zhang
Journal:  N Engl J Med       Date:  2008-08-27       Impact factor: 91.245

9.  Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand.

Authors:  Martin B Wax; Gülgün Tezel; Junjie Yang; Guanghua Peng; Rajkumar V Patil; Neeraj Agarwal; Rebecca M Sappington; David J Calkins
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

10.  Toll-like receptor 4 restricts retinal progenitor cell proliferation.

Authors:  Ravid Shechter; Ayal Ronen; Asya Rolls; Anat London; Sharon Bakalash; Michael J Young; Michal Schwartz
Journal:  J Cell Biol       Date:  2008-11-03       Impact factor: 10.539

View more
  68 in total

1.  Toll-like receptors 4, 5, 6 and 7 are constitutively expressed in non-human primate retinal neurons.

Authors:  Monica M Sauter; Aaron W Kolb; Curtis R Brandt
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

2.  Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma.

Authors:  Dongwook Lee; Myoung Sup Shim; Keun-Young Kim; You Hyun Noh; Heemin Kim; Sang Yeop Kim; Robert N Weinreb; Won-Kyu Ju
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

Review 3.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

Review 4.  Neuroinflammation and microglia in glaucoma: time for a paradigm shift.

Authors:  Xin Wei; Kin-Sang Cho; Eric F Thee; Martine J Jager; Dong Feng Chen
Journal:  J Neurosci Res       Date:  2018-05-18       Impact factor: 4.164

5.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

6.  Alterations in molecular pathways in the retina of early experimental glaucoma eyes.

Authors:  Li Cao; Lin Wang; Grant Cull; An Zhou
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

7.  Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

Review 8.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

Review 9.  The complex role of neuroinflammation in glaucoma.

Authors:  Ileana Soto; Gareth R Howell
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-03       Impact factor: 6.915

10.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.